Partnership with Sunlight

Apr 02, 2018

Rochem International is pleased to announce our continued Exclusive Strategic Partnership with Changzhou Sunlight Pharmaceutical Co., Ltd. (Sunlight). Rochem has been partners with Sunlight for nearly 20 years in the North American market and each has been highly influential in the other’s continued growth and success. As an exclusive strategic partner, Rochem has worked closely with Sunlight to bring their Benzocaine facility into compliance with both U.S. and EU cGMP standards. Moving forward, Rochem and Sunlight look to work together in new product development as well explore finished product in the Chinese market.

Related Posts